Spinelli, F., Conti, F., Caporali, R., Iannone, F., Cacciapaglia, F. and Steering Committee of the Italian Society of Rheumatology, on behalf of the 2023. Janus kinase inhibitors: between prescription authorization and reimbursability. Reumatismo. 75, 4 (Dec. 2023). DOI:https://doi.org/10.4081/reumatismo.2023.1627.